Shows
PeDRA PearlsOX40: Innovative Insights DiscussionFollowing the June 23 OX40 webinar, Dr. Eichenfield, Dr. Simpson, and Dr. Wan continue the conversation with a look ahead at the future of OX40 therapies and their potential to change the course of disease. They also unpack the complex concept of remission in atopic dermatitis—what it means, how it's defined, and whether it's truly achievable.To watch the OX40 webinar, please click here.Disclosures:Lawrence Eichenfield, MD has served as a consultant, speaker, advisory board member, or investigator for AbbVie, Acrotech, Almirall, Amgen, Apogee, Arcutis, Attovia, Bristol Myers Squibb, Castle Biosciences, CorEvitas, De...2025-06-3043 min
PeDRA PearlsOX40: Innovative Insights and Therapeutic Potential in Pediatric DermatologyThis engaging and informative webinar explores the role of OX40 and OX40L in pediatric dermatology. OX40: Innovative Insights and Therapeutic Potential in Pediatric Dermatology brings together experts in the field to discuss emerging research, mechanisms of action, and the implications of targeting the OX40 pathway for treating chronic inflammatory skin diseases in children. To view the video version of this webinar, please click here. Disclosures:Lawrence Eichenfield, MD has served as a consultant, speaker, advisory board member, or investigator for AbbVie, Acrotech, Almirall, Amgen, Apogee, Arcutis, Attovia, Bristol Myers Squibb, Castle Biosciences, CorEvitas, Dermavant...2025-06-2351 min
PETRI DISH PERSPECTIVES: BIOTECH UNLEASHEDEpisode 7: SanofiSend us a textEver wonder how an oil conglomerate helped create one of the world’s top pharma giants? 💥 In this episode of Petri Dish Perspectives: Biotech Unleashed, your host, Manead, dives into the fascinating story of Sanofi, a company whose name you’ve probably seen on insulin pens 💉, flu shots 🦠, and blockbuster immunology meds 💊.We explore: 🔹 Sanofi’s wild beginnings inside a French oil giant 🛢️ 🔹 Game-changing acquisitions — Aventis, Genzyme, and more 💸 🔹 Lantus and its dominance in diabetes care 🧃 🔹 Vaccine legacy from Louis Pasteur to COVID-19 🧫 🔹 The Dupixent boom and Regeneron partnership 🤝 🔹 Bold...2025-06-1212 min
Rare Disease DiscussionsFabry Disease Research HighlightsThis program is supported by educational grants from Amicus Therapeutics, Inc. and Chiesi USA Inc.Fabry disease is an inherited lysosomal storage disease caused by mutations in the GLA gene, disrupting the function of the enzyme, α-galactosidase. This results in the accumulation of globotriaosylceramide (GL-3) and its deacylated form, globotriaosylsphingosine (lyso-GL-3), leading to progressive disruption of multiple organ systems. There are currently three treatment options available for Fabry disease, including two enzyme replacement therapies, agalsidase beta and pegunigalsidase alfa, and a chaperone therapy, migalastat. There are also other treatments in development (e.g., gene therapy, other en...2025-05-2725 min
PedsCases: Pediatric Education OnlineCongenital HemangiomasThis episode of PedsCases will give you an approach to congenital hemangiomas. By the end of this podcast, listeners will be able to 1) define hemangiomas and congenital hemangiomas, 2) explain the genetics and environmental factors associated with congenital hemangiomas, 3) describe the pathogenesis of congenital hemangiomas, 4) classify congenital hemangiomas, and 5) discuss the diagnosis, differential diagnosis, and management strategies for congenital hemangiomas. Today’s episode was created by Emilie Wang, a medical student at the University of British Columbia, in collaboration with Dr. Joseph Lam, a pediatric dermatologist at BC Children’s Hospital. An author of this podcast has financial supp...2025-05-1418 min
Biotech 2050 PodcastDavid Meeker, CEO of Rhythm Pharmaceuticals, on Rare Disease Breakthroughs & Biotech’s FutureSynopsis:
Join host Alok Tayi as he welcomes David Meeker, CEO of Rhythm Pharmaceuticals, for an inspiring conversation on the transformative journey of rare disease biotech. David shares his incredible path from practicing physician to biotech visionary, recounting his experiences at Genzyme, where he helped shape the rare disease business model and set the stage for a wave of life-changing innovations.
In this episode, David dives deep into the breakthroughs and hurdles of developing therapies for rare diseases, the pivotal role of patient-centric approaches, and how advancements in precision medicine are reshaping treatment for conditions like genetic obesity. He also...2025-01-2958 min
PeerView Oncology & Hematology CME/CNE/CPE Video PodcastThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SKH865. CME/MOC/AAPA/IPCE credit will be available until March 20, 2025.Making Precision Decisions in the Treatment of NSCLC With Common and Uncommon EGFR Mutations: How to Navigate the Expanding Options and Increasing Complexity In support of improving...2024-03-1552 min
PeerView Internal Medicine CME/CNE/CPE Video PodcastThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SKH865. CME/MOC/AAPA/IPCE credit will be available until March 20, 2025.Making Precision Decisions in the Treatment of NSCLC With Common and Uncommon EGFR Mutations: How to Navigate the Expanding Options and Increasing Complexity In support of improving...2024-03-1552 minPeerView Oncology & Hematology CME/CNE/CPE Video PodcastAmy Shapiro, MD - A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient PopulationsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJM865. CME/MOC/AAPA/IPCE credit will be available until March 12, 2025.A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient Populations In support of improving patient care, PVI, PeerView...2024-03-151h 06
PeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SKH865. CME/MOC/AAPA/IPCE credit will be available until March 20, 2025.Making Precision Decisions in the Treatment of NSCLC With Common and Uncommon EGFR Mutations: How to Navigate the Expanding Options and Increasing Complexity In support of improving...2024-03-1552 minPeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastAmy Shapiro, MD - A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient PopulationsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJM865. CME/MOC/AAPA/IPCE credit will be available until March 12, 2025.A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient Populations In support of improving patient care, PVI, PeerView...2024-03-151h 06
PeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SKH865. CME/MOC/AAPA/IPCE credit will be available until March 20, 2025.Making Precision Decisions in the Treatment of NSCLC With Common and Uncommon EGFR Mutations: How to Navigate the Expanding Options and Increasing Complexity In support of improving...2024-03-1552 minPeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastAmy Shapiro, MD - A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient PopulationsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJM865. CME/MOC/AAPA/IPCE credit will be available until March 12, 2025.A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient Populations In support of improving patient care, PVI, PeerView...2024-03-151h 06PeerView Internal Medicine CME/CNE/CPE Video PodcastAmy Shapiro, MD - A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient PopulationsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJM865. CME/MOC/AAPA/IPCE credit will be available until March 12, 2025.A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient Populations In support of improving patient care, PVI, PeerView...2024-03-151h 06
PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SKH865. CME/MOC/AAPA/IPCE credit will be available until March 20, 2025.Making Precision Decisions in the Treatment of NSCLC With Common and Uncommon EGFR Mutations: How to Navigate the Expanding Options and Increasing Complexity In support of improving...2024-03-1552 min
PeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastAdam Friedman, MD, FAAD - Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous PemphigoidThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SVX865. CME/MOC/AAPA credit will be available until March 7, 2025.Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous Pemphigoid2024-03-152h 17
PeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastAdam Friedman, MD, FAAD - Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous PemphigoidThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SVX865. CME/MOC/AAPA credit will be available until March 7, 2025.Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous Pemphigoid2024-03-152h 18
PeerView Clinical Pharmacology CME/CNE/CPE VideoThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SKH865. CME/MOC/AAPA/IPCE credit will be available until March 20, 2025.Making Precision Decisions in the Treatment of NSCLC With Common and Uncommon EGFR Mutations: How to Navigate the Expanding Options and Increasing Complexity In support of improving...2024-03-1552 minPeerView Clinical Pharmacology CME/CNE/CPE VideoAdam Friedman, MD, FAAD - Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous PemphigoidThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SVX865. CME/MOC/AAPA credit will be available until March 7, 2025.Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous Pemphigoid2024-03-152h 18
PeerView Internal Medicine CME/CNE/CPE Audio PodcastAmy Shapiro, MD - A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient PopulationsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJM865. CME/MOC/AAPA/IPCE credit will be available until March 12, 2025.A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient Populations In support of improving patient care, PVI, PeerView...2024-03-151h 06PeerView Internal Medicine CME/CNE/CPE Audio PodcastThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SKH865. CME/MOC/AAPA/IPCE credit will be available until March 20, 2025.Making Precision Decisions in the Treatment of NSCLC With Common and Uncommon EGFR Mutations: How to Navigate the Expanding Options and Increasing Complexity In support of improving...2024-03-1552 min
PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastAmy Shapiro, MD - A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient PopulationsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJM865. CME/MOC/AAPA/IPCE credit will be available until March 12, 2025.A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient Populations In support of improving patient care, PVI, PeerView...2024-03-151h 06PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SKH865. CME/MOC/AAPA/IPCE credit will be available until March 20, 2025.Making Precision Decisions in the Treatment of NSCLC With Common and Uncommon EGFR Mutations: How to Navigate the Expanding Options and Increasing Complexity In support of improving...2024-03-1552 minPeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastAdam Friedman, MD, FAAD - Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous PemphigoidThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SVX865. CME/MOC/AAPA credit will be available until March 7, 2025.Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous Pemphigoid2024-03-152h 17PeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastAmy Shapiro, MD - A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient PopulationsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJM865. CME/MOC/AAPA/IPCE credit will be available until March 12, 2025.A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient Populations In support of improving patient care, PVI, PeerView...2024-03-151h 06PeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastAmy Shapiro, MD - A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient PopulationsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJM865. CME/MOC/AAPA/IPCE credit will be available until March 12, 2025.A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient Populations In support of improving patient care, PVI, PeerView...2024-03-151h 06PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastAmy Shapiro, MD - A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient PopulationsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJM865. CME/MOC/AAPA/IPCE credit will be available until March 12, 2025.A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient Populations In support of improving patient care, PVI, PeerView...2024-03-151h 06PeerView Clinical Pharmacology CME/CNE/CPE VideoAmy Shapiro, MD - A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient PopulationsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJM865. CME/MOC/AAPA/IPCE credit will be available until March 12, 2025.A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient Populations In support of improving patient care, PVI, PeerView...2024-03-151h 06
PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...2024-03-011h 24PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...2024-03-011h 25PeerView Oncology & Hematology CME/CNE/CPE Video PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...2024-03-011h 24PeerView Clinical Pharmacology CME/CNE/CPE VideoRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...2024-03-011h 24PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...2024-03-011h 25
PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...2024-03-011h 25
S&S On Biotech2.4 When is a deal not a deal. Sanofi makes a big bet in AATDSanofi’s partial acquisition of Inhibrx recalls earlier transactions, such as Pfizer’s acquisition of BioHaven or, to go back even further, Johnson & Johnson’s acquisition of Actelion, in which assets deemed surplus to the acquirer’s needs were spun out into new entities. In the case of Inhibrx, Sanofi wanted just one programme, INBRX-101, its investigational drug for alpha1-anti-trypsin deficiency (AATD), a genetic condition arising from a point mutation in the SERPINA1 gene, which encodes alpha-1 antitrypsin. The protein is produced in and exported from the liver and plays a key protective rule in the lungs. 2024-02-0323 minPeerView Oncology & Hematology CME/CNE/CPE Video PodcastNeal D. Shore, MD, FACS - Pioneering Precision Medicine in Bladder Cancer: Multidisciplinary Perspectives on Personalizing Patient CareThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/XJV865. CME/MOC/AAPA credit will be available until December 28, 2024.Pioneering Precision Medicine in Bladder Cancer: Multidisciplinary Perspectives on Personalizing Patient Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute...2024-01-181h 01PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video PodcastNeal D. Shore, MD, FACS - Pioneering Precision Medicine in Bladder Cancer: Multidisciplinary Perspectives on Personalizing Patient CareThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/XJV865. CME/MOC/AAPA credit will be available until December 28, 2024.Pioneering Precision Medicine in Bladder Cancer: Multidisciplinary Perspectives on Personalizing Patient Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute...2024-01-181h 01PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Pioneering Precision Medicine in Bladder Cancer: Multidisciplinary Perspectives on Personalizing Patient CareThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/XJV865. CME/MOC/AAPA credit will be available until December 28, 2024.Pioneering Precision Medicine in Bladder Cancer: Multidisciplinary Perspectives on Personalizing Patient Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute...2024-01-181h 01PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Pioneering Precision Medicine in Bladder Cancer: Multidisciplinary Perspectives on Personalizing Patient CareThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/XJV865. CME/MOC/AAPA credit will be available until December 28, 2024.Pioneering Precision Medicine in Bladder Cancer: Multidisciplinary Perspectives on Personalizing Patient Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute...2024-01-181h 01PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastAmy Shapiro, MD and Prof Pratima Chowdary, MD, FRCPATH- The ‘Clot’ Thickens in the Hemophilia Story: Clinical Perspectives on Enhancing Outcomes With Innovative Non-Factor TherapyThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/YXF865. CME/MOC credit will be available until December 31, 2024.The ‘Clot’ Thickens in the Hemophilia Story: Clinical Perspectives on Enhancing Outcomes With Innovative Non-Factor TherapyPenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCM...2024-01-181h 15PeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastAmy Shapiro, MD and Prof Pratima Chowdary, MD, FRCPATH- The ‘Clot’ Thickens in the Hemophilia Story: Clinical Perspectives on Enhancing Outcomes With Innovative Non-Factor TherapyThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/YXF865. CME/MOC credit will be available until December 31, 2024.The ‘Clot’ Thickens in the Hemophilia Story: Clinical Perspectives on Enhancing Outcomes With Innovative Non-Factor TherapyPenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCM...2024-01-181h 15PeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastAmy Shapiro, MD and Prof Pratima Chowdary, MD, FRCPATH- The ‘Clot’ Thickens in the Hemophilia Story: Clinical Perspectives on Enhancing Outcomes With Innovative Non-Factor TherapyThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/YXF865. CME/MOC credit will be available until December 31, 2024.The ‘Clot’ Thickens in the Hemophilia Story: Clinical Perspectives on Enhancing Outcomes With Innovative Non-Factor TherapyPenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCM...2024-01-181h 15PeerView Clinical Pharmacology CME/CNE/CPE VideoNeal D. Shore, MD, FACS - Pioneering Precision Medicine in Bladder Cancer: Multidisciplinary Perspectives on Personalizing Patient CareThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/XJV865. CME/MOC/AAPA credit will be available until December 28, 2024.Pioneering Precision Medicine in Bladder Cancer: Multidisciplinary Perspectives on Personalizing Patient Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute...2024-01-181h 01PeerView Clinical Pharmacology CME/CNE/CPE VideoAmy Shapiro, MD and Prof Pratima Chowdary, MD, FRCPATH- The ‘Clot’ Thickens in the Hemophilia Story: Clinical Perspectives on Enhancing Outcomes With Innovative Non-Factor TherapyThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/YXF865. CME/MOC credit will be available until December 31, 2024.The ‘Clot’ Thickens in the Hemophilia Story: Clinical Perspectives on Enhancing Outcomes With Innovative Non-Factor TherapyPenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCM...2024-01-181h 15PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Pioneering Precision Medicine in Bladder Cancer: Multidisciplinary Perspectives on Personalizing Patient CareThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/XJV865. CME/MOC/AAPA credit will be available until December 28, 2024.Pioneering Precision Medicine in Bladder Cancer: Multidisciplinary Perspectives on Personalizing Patient Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute...2024-01-181h 01S&S On Biotech2.1 The FTC vs. Sanofi. Stifling innovation or smashing monopolies?In its own words, the U.S. Federal Trade Commission’s opposition to a licensing deal between Sanofi and the biotechnology firm Maze Therapeutics, “is a case about a monopolist seeking to eliminate a nascent threat to its monopoly”. Cue howls of complaint by VC’s and public market investors that government scrutiny is preventing innovation. True enough, acquisitions, mergers and licensing transactions between biotech companies and bigger biotech or pharma companies are the lifeblood of the sector. On the other hand, no one wants a big pharma company to acquire close to a monopoly position w...2024-01-1226 minPeerView Oncology & Hematology CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04PeerView Internal Medicine CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04PeerView Oncology & Hematology CME/CNE/CPE Video PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04PeerView Clinical Pharmacology CME/CNE/CPE VideoNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04PeerView Internal Medicine CME/CNE/CPE Video PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04
mentors - le leadership en santéChristian Deleuze (4/4) - S’inscrire dans la duréeChristian Deleuze est très certainement l’une des personnes les plus généreuses et les plus humbles que j’ai eu le privilège de rencontrer. Ce premier épisode nous plonge dans la vie et le parcours d’une des figures emblématiques de l’industrie pharmaceutique française. Christian Deleuze a démarré sa carrière en tant que médecin, avant de rapidement rejoindre la pharma pour mettre sa passion au service des autres. Ces 10 dernières années il a occupé la Présidence du laboratoire Sanofi Genzyme, poste qu’il a quitté en novembre 2021 pour devenir...2022-06-2213 min
mentors - le leadership en santéChristian Deleuze (3/4) - Être manager, devenir leaderChristian Deleuze est très certainement l’une des personnes les plus généreuses et les plus humbles que j’ai eu le privilège de rencontrer. Ce premier épisode nous plonge dans la vie et le parcours d’une des figures emblématiques de l’industrie pharmaceutique française. Christian Deleuze a démarré sa carrière en tant que médecin, avant de rapidement rejoindre la pharma pour mettre sa passion au service des autres. Ces 10 dernières années il a occupé la Présidence du laboratoire Sanofi Genzyme, poste qu’il a quitté en novembre 2021 pour devenir...2022-06-1613 min
mentors - le leadership en santéChristian Deleuze (2/4) - S'adapter au changementChristian Deleuze est très certainement l’une des personnes les plus généreuses et les plus humbles que j’ai eu le privilège de rencontrer. Ce premier épisode nous plonge dans la vie et le parcours d’une des figures emblématiques de l’industrie pharmaceutique française. Christian Deleuze a démarré sa carrière en tant que médecin, avant de rapidement rejoindre la pharma pour mettre sa passion au service des autres. Ces 10 dernières années il a occupé la Présidence du laboratoire Sanofi Genzyme, poste qu’il a quitté en novembre 2021 pour devenir...2022-06-0914 min
mentors - le leadership en santéChristian Deleuze (1/4) - Bâtir une vie harmonieuseChristian Deleuze est très certainement l’une des personnes les plus généreuses et les plus humbles que j’ai eu le privilège de rencontrer. Ce premier épisode nous plonge dans la vie et le parcours d’une des figures emblématiques de l’industrie pharmaceutique française. Christian Deleuze a démarré sa carrière en tant que médecin, avant de rapidement rejoindre la pharma pour mettre sa passion au service des autres. Ces 10 dernières années il a occupé la Présidence du laboratoire Sanofi Genzyme, poste qu’il a quitté en novembre 2021 pour devenir...2022-06-0213 min
Canadian Urological Association (CUA)V2P2 2022 - An Update in Advanced Prostate CancerDisclosures:Fred SaadGrants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, SanofiEleni EfstathiouResearch Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, NuvationScientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant
2022-02-101h 01Canadian Urological Association (CUA)V2P2 2022 - An Update in Advanced Prostate Cancer - FrenchDisclosures:Fred SaadGrants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, SanofiEleni EfstathiouResearch Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, NuvationScientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant
2022-02-101h 01
LOOP Casts9: Senem Korol - Sanofi Genzyme Uluslararası & Çin İK İş OrtağıHayatın her evresinde sosyal etkileşimden beslenmek… Yardım istemek, pedal çevirmek ve arada bir köküne dönmek… Sanofi Genzyme Uluslararası & Çin İK İş Ortağı Senem Korol’la harika bir sohbet…2021-12-2914 min
En Kvart om Typ 2En Kvart om Typ Två - Avslut säsong 1Varmt välkomen till En Kvart Om Typ Två. En podcast för dig som arbetar med, berörs eller forskar om atopiska sjukdomar. Lyssna in i ca 15 minuter för att t a del av när Sveriges specialister inom Typ 2-inflammation delar med sig av sin kunskap och erfarenhet. En Kvart Om Typ 2 ges ut av Sanofi Genzyme MAT-SE-2100844(v1.0)Augusti 20212021-09-0801 min
Health Professional Radio - PodcastSanofi Genzyme - Humanitarian Aid Program to Treat Rare DiseasesShannon Resetich, Global Franchise Head, Rare Diseases at Sanofi Genzyme discusses the company's Humanitarian Aid Program started 30 years ago. The program is largely focused on patients with lysosomal storage disorder (LSDs) diseases who need enzyme replacement therapies. She talks about how this humanitarian program helps to ensure patients with LSDs have access to treatment no matter where they are located or what they can afford. She also discusses how the program works effectively, the partnerships they have forged and the support that the program provides to elevate the standards for rare disease care in the communities around the world. She...2021-09-0309 min
Inspiring Women with Laurie McGrawEP. 48 Pay it forward and give back, Sound advice from Marie Lamont.
Laurie McGraw is speaking with Inspiring Woman Marie E. Lamont, President and Chief Operating Officer of Inteliquet, a clinical trials technology company.
Marie E. Lamont is responsible for the overall vision and operations of Inteliquet. With the goal of providing patients and physicians access to the latest and best treatment options and care available, she helps commercialize Inteliquet’s offerings of intelligent technology, insights, and services to improve the clinical trial process, research, and translational medicine.
With more than 25 years as a global biotech leader, Marie has significant commercial and operational expertise. Sh...2021-08-1727 min
The Role of IL-6 in RA: Expert PerspectivesElevated IL-6 As a Contributor to Cardiovascular Effects in Patients with RA (with Dr. Leonard Calabrese)Patients with rheumatoid arthritis have an increased risk of cardiovascular effects when compared with those who do not have RA. IL-6 is a proinflammatory and pleiotropic cytokine that, when elevated, contributes to cardiovascular manifestations seen in RA, including atherogenic and prothrombotic effects. Visit www.RAandIL6.com to learn more about the broad and important role that IL-6 plays in RA.
Featured Guest: Dr. Leonard Calabrese, DO, heads Cleveland Clinic’s Section of Clinical Immunology and manages its Clinical Immunology Clinic. He has lectured nationally and internationally on clinical immunology and rheumatology, and is the author of over 400 pu...2021-08-0921 minThe Role of IL-6 in RA: Expert PerspectivesBone Resorption: A Manifestation of RA Mediated by Elevated IL-6 (with Dr. Robin Dore)RA is associated with systemic bone remodeling leading to bone loss. Under normal conditions, proinflammatory cytokines, including IL-6, regulate bone remodeling. However, in patients with RA, IL-6 promotes bone resorption. IL-6 contributes to bone resorption by stimulating RANKL expression and autoantibody production. Visit www.RAandIL6.com to learn more about the broad and important role that IL-6 plays in RA.
Featured Guest: Dr. Robin Dore, MD, is a rheumatologist in private practice in Tustin, CA and a Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA. She is also certified as a clinical...2021-08-0914 minThe Role of IL-6 in RA: Expert PerspectivesThe Wide-Reaching Effects of Pain and IL-6 in Rheumatoid Arthritis (with Ms. Amanda Mixon)Pain consistently ranks as one of the leading concerns among patients with rheumatoid arthritis. Identification of the major players in the mechanism of pain, such as interleukin-6 (IL-6) is a necessary step toward the understanding of pain associated with RA. IL-6, a proinflammatory and pleiotropic cytokine with activities that contribute to the foundation of RA pathogenesis, also facilitates the inflammatory pain observed in RA. Visit www.RAandIL6.com to learn more about the broad and important role that IL-6 plays in RA.
Featured Guest: Ms. Amanda Mixon is a Physician Assistant at the Colorado Center for Arthritis...2021-08-0919 minThe Role of IL-6 in RA: Expert PerspectivesThe Role of IL-6 in HPA–Axis-Related Manifestation in RA (with Dr. Sanjay Chabra)Rheumatoid arthritis is more than a disease of the joints and often has neuroendocrine and neurological systemic manifestations, such as pain, fatigue, mood disorders, and sleep disorders. Elevated levels of proinflammatory cytokines including interleukin-6, or IL-6, are associated with these manifestations through their role on the hypothalamic-pituitary-adrenal axis, or the HPA axis—a major part of the neuroendocrine system that maintains and reinstates homeostasis in the body following stress. Knowledge of the effects of elevated IL-6 on the HPA axis is important to understand the negative symptoms associated with RA. Visit www.RAandIL6.com to learn more about the br...2021-08-0915 minThe Role of IL-6 in RA: Expert PerspectivesIL-6: A Key Link Between Innate and Adaptive Immune Responses in RA (with Dr. Gordon Lam)Rheumatoid arthritis is characterized by the activation of the innate and adaptive immune systems, driven by a network of cytokines including tumor necrosis factor and interleukins 1, 17, and 6. Persistently elevated IL-6, in particular, influences the response of both innate and adaptive immune systems. This podcast explores the role of IL-6 in the innate and adaptive immune systems and how elevated IL-6 leads to autoimmunity, inflammation, joint destruction, and systemic manifestations of RA. Visit www.RAandIL6.com to learn more about the broad and important role that IL-6 plays in RA.
Featured Guest: Dr. Gordon Lam, MD, is the...2021-08-0923 minThe Role of IL-6 in RA: Expert PerspectivesA Deeper Dive Into IL-6 Pathway Activation and Downstream Signaling in RA (with Dr. Alvin Wells)IL-6 is a proinflammatory cytokine that activates three distinct signaling pathways implicated in RA: MAPK, JAK/STAT, and PI3K. Additionally, the unique signaling mechanism of IL-6 differs from JAK, TNF-alpha, and IL-6 signaling. Visit www.RAandIL6.com to learn more about the broad and important role that IL-6 plays in RA.
Featured Guest: Dr. Alvin Wells, MD, PhD, is currently a practicing rheumatologist and Director at Aurora Rheumatology and Immunotherapy Center in Franklin, WI. He received his MD from the University of South Florida, and his PhD in Immunology from the University of South Carolina. A...2021-08-0920 minThe Role of IL-6 in RA: Expert PerspectivesDual Signaling: The Driver Behind the Pleiotropic Nature of IL-6 (with Dr. Alan Epstein)Persistently elevated levels of IL-6 can contribute to the disruption of homeostasis in many cell types and physiologic processes throughout the body. The widespread effects of IL-6 stem from its versatile dual-signaling, which allows it to interact with a broad range of cells and tissues. Dual signaling occurs through both membrane-bound and soluble forms of IL-6 receptors, allowing for more widespread effects and therefore making IL-6 an important contributor to manifestations of RA. Visit www.RAandIL6.com to learn more about the broad and important role that IL-6 plays in RA.
Featured Guest: Dr. Alan Epstein...2021-08-0914 min
The Role of IL-6 in RA: Expert PerspectivesBeyond the Joints: Systemic Manifestations of IL-6 Elevation in Rheumatoid Arthritis (with Dr. Grace Wright)Rheumatoid arthritis (RA) is a chronic, systemic, and debilitating autoimmune disease often associated with just the joints. But it is also characterized by systemic manifestations that affect the nervous, endocrine, cardiovascular, and metabolic systems. This podcast explores systemic manifestations of RA related to these systems and the role that IL-6 plays in these manifestation. Visit www.RAandIL6.com to learn more about the broad and important role that IL-6 plays in RA.
Featured Guest: Dr. Grace Wright, MD, PhD, is a consultant rheumatologist in New York City and is the Founder/President of the Association of...2021-08-0924 min
RARECastDelivering Rare Disease Therapies to Patients in NeedWhen Genzyme won approval for an enzyme replacement therapy for Gaucher disease in 1991, the company launched a humanitarian aid program for rare diseases. Now as part of Sanofi, the pharmaceutical company has continued and expanded the program, which now includes five different lysosomal storage disorders, as well as rare blood disorders. We spoke to Bill Sibold, executive vice president of Sanofi Genzyme and president of Sanofi North America, about the company’s Humanitarian Aid Program, how it works; and how it overcomes the regulatory, infrastructure, and medical challenges of delivering these treatments to patients around the globe.2021-08-0520 min
Et sjeldent perspektivKraften av en diagnoseHvorfor er det så avgjørende å få en diagnose? Og hvordan er det for pårørende å få vite at det som feiler ens eget barn ikke bare er alvorlig, men også sjeldent? I denne episoden blir vi bedre kjent med Løvemamma Bettina, som er mor til tre barn under utredning for sjeldne diagnoser. MAT-NO-2100412-May 2021 2021-06-0943 minEt sjeldent perspektivPsykisk helse på veien til en sjelden diagnose del 1For mange er det en stor lettelse å få stilt en sjelden diagnose, men på den andre siden kan det også være knusende å sitte på fasiten om hva fremtiden kan bringe. I denne episoden møter vi foreldrene Maiken, Anne og Nicolai, som har ulike perspektiver på den psykiske belastningen det er å vite, eller å ikke vite. MAT-NO-21004252021-06-0824 minEt sjeldent perspektivPsykisk helse på veien til en sjelden diagnose del 2For mange er det en stor lettelse å få stilt en sjelden diagnose, men på den andre siden kan det også være knusende å sitte på fasiten om hva fremtiden kan bringe. I denne episoden møter vi foreldrene Maiken, Anne og Nicolai, som har ulike perspektiver på den psykiske belastningen det er å vite, eller å ikke vite. MAT-NO-2100470 2021-06-0824 minEt sjeldent perspektivHvor godt kjenner du din familiehistorikk?Mange sjeldne diagnoser har et genetisk opphav – nettopp derfor er familiehistorikken så viktig i søken etter en diagnose. Men hva skjer når vi begynner å lete i genene – finnes det svar vi helst skulle vært foruten? I denne episoden er det arv og genetikk som står i sentrum og programleder Karoline deler sin historie. 2021-05-2033 minEt sjeldent perspektivDiagnosejaktenHva betyr det egentlig at en diagnose er sjelden? Og hvorfor er det så viktig å finne disse diagnosene? I denne episoden møter panelet Marit som fødte en tilsynelatende frisk jente i 1995. Senere ble datteren diagnostisert, som en av de første i Norge, med det sjeldne syndromet VCFS. 2021-05-2028 minEt sjeldent perspektivDet menneskelige biblioteketInne i oss alle finnes det en kode som forteller cellene i kroppen hvordan de skal lage og vedlikeholde oss. Om vi skal ha blå øyne, om vi har brunt hår, og om vi er disponible for sykdom. For å finne ut om noen har en sjelden diagnose, er man ofte nødt til å lete i denne koden. I denne episoden utforsker panelet hvordan man saumfarer «det menneskelige biblioteket». 2021-05-2018 minEt sjeldent perspektivNår symptomer blir mistolket og riktig diagnose uteblirHadde livet vært annerledes hvis man visste da, det man vet nå? Altfor mange tidlige symptomer blir mistolket, og enkelte lever lenge med feil eller ingen diagnose, og dermed uten riktig behandling. I denne episoden møter vi Jørgen, som ble diagnostisert med et sjeldent syndrom 14 år etter at han opplevde de første symptomene. 2021-05-2028 minEn Kvart om Typ 2En Kvart Om Typ Två - IntroVarmt välkommen till En Kvart Om Typ Två. En podcast för dig som arbetar med, berörs eller forskar om atopiska sjukdomar. Lyssna in i ca 15 minuter för att ta del av när Sveriges specialister inom Typ 2-inflammation delar med sig av sin kunskap och erfarenhet. En Kvart Om Typ 2 ges ut av Sanofi Genzyme.Vid synpunkter, förslag på samtalsämnen eller frågor kan ni skriva till oss på enkvartomtyp2@sanofi.comMAT-SE-2100423 (V.1.0) April 20212021-04-2003 min
RealTalk MSManaging Your Cognitive Health in MS with Dr. Victoria LeavittMore than half of all the people living with MS will develop problems with cognition. And while experiencing cognitive dysfunction can be challenging and frustrating, these kinds of changes can also be frightening. Joining me to talk about things you can do to better manage cognitive changes and preserve healthy cognition is neuroscientist and neuropsychologist, Dr. Victoria Leavitt. We're also talking about the encouraging results from a small clinical trial that tested stem cell therapy to treat progressive MS. We'll tell you about a person living with secondary progressive MS who...2021-04-0631 min
Health Professional Radio - PodcastInteliquet - The Effect of COVID on Clinical TrialsMarie E. Lamont, President and Chief Operating Officer at Inteliquet™, a leader in clinical trial matching, discusses the impact COVID has had on clinical trials and how companies have leveraged advanced technology tools to further research, improve patient recruitment, and use AI and Machine Learning to recognize behaviors and patterns to constantly improve on the data collection process overall.
Marie E. Lamont is responsible for the overall vision and operations of Inteliquet. With the goal of providing patients and physicians access to the latest and best treatment options and care available, she helps commercialize Inteliquet’s offerings of i...2021-03-1412 min
Health Professional Radio - PodcastRare Genetic DiseasesGeneticist, Dr. Jennifer Ibrahim, MD, Head of North America Medical Affairs, Rare Disease at Sanofi Genzyme discusses rare genetic disease, why it's so hard to diagnose, and the important role of genetic counselors for families who had a history of a rare genetic disease or learn of it. She talks about some new technologies and tests that are helping diagnose rare genetic diseases and what she anticipates will improve diagnosis and treatment moving forward.
Jennifer Ibrahim received her medical degree from New Jersey Medical School, trained in Pediatrics at Babies’ Hospital-Columbia University, and competed fellowship training in Human Genetics at th...2021-02-2812 minEt sjeldent perspektivTeaser: Et sjeldent perspektivKommer snart: «Et sjeldent perspektiv» tar for seg ulike utfordringer og viktige spørsmål på veien til en sjelden diagnose – sett fra ulike perspektiv. Programleder Karoline Marie Enoksen samler fageksperter og historier fra pasienter og pårørende, og gir et unikt innblikk i sjeldenfeltet. 2021-02-2201 min
Demystifying NMO & MOGVaccine PreparednessThe Covid-19 pandemic has ravaged the world, and while we're going through another dark surge, there is hope- vaccines. The FDA just authorized and approved the first Covid-19 vaccine. While this is exciting, it also brings up a lot of questions, especially for people in the NMO community. In this episode, host Chelsey, PhD immunologist, chats with Sumaira on the basics of vaccines, and then talks with neuroimmunologist and NMO clinician Mary Rensel, MD of the Cleveland Clinic Mellen Center. Sumaira and Chelsey cover the basics on vaccines: What are vaccines? What's protective immunity? What's herd immunity? What're the...2020-12-1432 min
Leadership ConfessionsNicole Farmer, General Manager, Sanofi GenzymeThis week we hear from Nicole Farmer, UK&I General Mgr for Sanofi Genzyme and the importance of purpose in leadership. She shares how she balances her role at both work and at the Samaritans, whilst being a Mum and training for IronMan. Brought to you by Clarity Leadership - Thoughts, ideas and inspiration for businesses:https://www.clarityleadership.co.uk Hosted on Acast. See acast.com/privacy for more information.2020-12-0834 min
Dermatology WeeklyPediatric atopic dermatitis - What's new? And depression risk with isotretinoin; topical tapinarof is effectiveDermatology News: Who’s at risk for depression on isotretinoin?: https://bit.ly/32AioXp Topical tapinarof effective in pivotal psoriasis trials: https://bit.ly/3pma0o0 Methotrexate users need tuberculosis tests in high-TB areas: https://bit.ly/3f0DcMV * * * Keeping up with the literature on atopic dermatitis (AD) is a challenge, with eight new articles posted on PubMed a day in 2020. Vincent A. DeLeo, MD, talks to Lawrence F. Eichenfield, MD, about quality of life in pediatric AD patients and how the condition affects parents/guardians, particularly in the form of sleep disturbances. Dr. Eichenfield also...2020-11-1227 min
Hopkins Biotech PodcastJason Howard - Connecting Biotech & PhysiciansDr. Jason Howard, PhD is a Medical Science Liaison at Sanofi/Genzyme, where he provides field support for a metastatic prostate cancer treatment (cabazitaxel) and a squamous cell skin cancer treatment (cemiplimab). Prior to joining Sanofi, Jason worked at a Baltimore-based biotech startup called Vaccinogen, where he was co-inventor of the investigational cancer vaccine Oncavert. In this episode, we discuss the role of medical affairs in biotech & pharma, how to acquire & manage relationships with key opinion leaders (primarily physicians), how information collected in the field informs a biotech’s business strategy, and the em...2020-10-1941 min
Women In Government PodcastIt Takes 2: Type 2 InflammationWomen In Government Podcast
It Takes 2: Type 2 Inflammation
People of all ages, genders, and backgrounds are connected by similar challenges because of one lesser known chronic condition known as Type 2 Inflammation.
Recent scientific developments have shown that this overactive immune system response, underlies different atopic, allergic and inflammatory diseases. What exactly does that mean and how does it affect our families and communities?
On this episode of the Women In Government Podcast, our panel discusses how the type 2 inflammation connection can help patients work with their doctors to gain control of their chronic disease.
As for policymakers and industry leaders...2020-10-1224 min
Biotech 2050 Podcast33. RNA modification gene therapy for rare disorders, Jim Burns, CEO, Kathie Bishop, CSO, LocanabioJames Burns, PhD, Chief Executive Officer, Locanabio
James (Jim) Burns, Ph.D., joined Locanabio in December 2019 as CEO and Board member. Prior to joining Locanabio, Dr. Burns served as the CEO of Casebia Therapeutics and led the team in discovering and developing new CRISPR/Cas9-based breakthrough therapeutics to treat blood disorders, blindness and auto-immune disease. Prior to Casebia, Dr. Burns spent the bulk of his career at Sanofi-Genzyme, where he held several leadership roles with increasing responsibility, including North America Site Head for R&D where he coordinated R&D operations across key therapeutic areas, and head of Sanofi-Genzyme...2020-10-0727 min
Biotech2050 Podcast33.RNA modification gene therapy for rare disorders, Jim Burns, CEO, Kathie Bishop, CSO, LocanabioJames Burns, PhD, Chief Executive Officer, Locanabio
James (Jim) Burns, Ph.D., joined Locanabio in December 2019 as CEO and Board member. Prior to joining Locanabio, Dr. Burns served as the CEO of Casebia Therapeutics and led the team in discovering and developing new CRISPR/Cas9-based breakthrough therapeutics to treat blood disorders, blindness and auto-immune disease. Prior to Casebia, Dr. Burns spent the bulk of his career at Sanofi-Genzyme, where he held several leadership roles with increasing responsibility, including North America Site Head for R&D where he coordinated R&D operations...2020-10-0727 min
The MS PodcastMeasuring brain atrophy. What can be done and where are we heading?Guest host Svend Geertsen, Medical Advisor for MS in Sanofi Genzyme Denmark, will in this episode discuss the relevance and challenges with measuring brain atrophy with brain imaging experts Morten Blinkenberg, Senior Consultant at the Danish Multiple Sclerosis Center at Rigshospitalet, and Professor Hartwig Siebner, Head of Research at the Danish Research Centre for Magnetic Resonance at Hvidovre Hospital.
GZNO.MS.19.11.0310
MAT-GLB-2003317-v1.02020-04-1437 min
CFO THOUGHT LEADER555: Two Worlds One Career | Mike Kaseta, CFO, Aerami TherapeuticsFew megadeals within the past decade have received as many recurring kudos as the acquisition of Genzyme, of Cambridge, MA by France’s biggest pharmaceutical company, Sanofi. The marriage of Sanofi and Genzyme appears to have exceeded expectations, allowing all of those involved in minting the newly merged entity to rightfully keep a feather in their postmerger caps. Thus it was for Mike Kaseta, who in the wake of the merger found himself tasked with integrating the finance and IT functions of the two companies. “It’s probably the achievement that I’m most proud of in my...2019-12-1135 min
CFO THOUGHT LEADER555: Two Worlds One Career | Mike Kaseta, CFO, Aerami TherapeuticsFew megadeals within the past decade have received as many recurring kudos as the acquisition of Genzyme, of Cambridge, MA by France’s biggest pharmaceutical company, Sanofi. The marriage of Sanofi and Genzyme appears to have exceeded expectations, allowing all of those involved in minting the newly merged entity to rightfully keep a feather in their postmerger caps. Thus it was for Mike Kaseta, who in the wake of the merger found himself tasked with integrating the finance and IT functions of the two companies. “It’s probably the achievement that I’m most proud...2019-12-1135 min
PharmaPills - Pillole dal farmaceuticoPharmapills puntata n.92. Novità dall'assemblea generale ICH.PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano Lagravinese. In questa puntata parliamo di:Chiesi, Sanofi, Ricerca Sanitaria, International Council for Harmonisation, Diabete Autoimmune Latente, Alzheimer.Aziende: Chiesi, Sanofi Genzyme, Novartis, Amgen.Persone: Carmine Carboni (Policlinico Gemelli di Roma), Enrica Pagliacco (IEO), Francesca Santoni (Ospedale San Raffaele), Alessandra Biffi (AO di Padova), Giovanni Ferrara (Ospedale San Martino), Stefano Bonaccini (Presidente della Conferenza delle Regioni), Giulia Bongiorno (Ministro della Pubblica Amministrazione), Paolo Pozzilli (Università Campus Bio-Medico di Roma), David Reese (Amgen).Nuove terapie: Umi...2019-07-1710 minPharmaPills - Pillole dal farmaceuticoPharmapills puntata n. 74. Lavorare nel life science: l’Italia è tra i 10 migliori paesi al mondoPharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Roche, IQVIA, Novartis, Endocyte, Gilead, Sanofi Genzyme, Sarepta, Paragon, Recordati, Merck, FDA, Amgen, PPD, Kedrion Pharma.Persone: Valentina Raiola (Gilead), Enrico Piccinini (Sanofi), Markus Otto (Università di Ulm), Federico Verde (Università di Milano), Manuela Monti (GIDM), Claudia Passoni (IEO), Elisabetta Iannelli (Favo), Edoardo Spina (Università di Messina), Luigi Sinigaglia (Centro Specialistico Ortopedico Traumatologico Gaetano Pini).Nuove terapie: cariprazina, Amgevita.Patologie: sclerosi laterale amiotrofica, distrofia di Duchenne, schiz...2018-10-2411 min
Neurology® PodcastMarch 6 2018 Issue1. Featured Article: Relapse occurrence in women with multiple sclerosis during pregnancy in the new treatment era2. What’s Trending: Sleep architecture and risk of dementiaThis podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the March 6, 2018, issue of Neurology. In the first segment, Dr. Stacey Clardy talks with Dr. Raed Alroughani about his article on relapse recurrence during pregnancy in women with multiple sclerosis. In the second part of the podcast, you’ll hear Dr. Jeff Burns interviews Dr. Sudha Seshadri about sleep and dementia risk.DISCLOSURES: Dr. Clardy has received research support from Western Inst...2018-03-0524 minNeurology® PodcastDecember 5 2017 IssueShow description/summary:1) Long-term benefit of enzyme-replacement therapy in Pompe disease: A 5-year prospective study2) What’s Trending: ACTH or prednisolone for infantile ataxiaThis podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the December 5, 2017 issue of Neurology. In the first segment, Dr. Kelly Gwathmey talks with Dr. Nadine van der Beek about her paper on enzyme-replacement therapy in Pompe disease. In the second part of the podcast, Dr. Ted Burns focuses his interview with Dr. John Mytinger on the topic of ACTH or prednisolone for infantile ataxia. DISCLOSURES: Dr. Gwathmey reports no disclosures.Dr. va...2017-12-0419 minNeurology® PodcastJanuary 17 207 Issue1) Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome2) What's Trending: Upcoming changes regarding the Neurology® Resident & Fellow section 3) Topic of the Month: Neuromuscular topicsThis podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the January 17, 2017 issue of Neurology. In the first segment, Dr. Andy Southerland talks with Dr. Aneesh Singhal about his paper on glucocorticoid-associated worsening of reversible cerebral vasoconstriction syndrome. Dr. Ted Burns talks with Dr. Roy Strowd about upcoming changes regarding the Neurology Resident & Fellow section for our “What's Trending” feature of the week. In the next part of the podcast, Dr. Ted Burns focus...2017-01-1727 min